Organic compounds

Details for Australian Patent Application No. 2008340017 (hide)

Owner Novartis AG

Inventors Assaraf, Yehuda G.; Jostock, Thomas; Knopf, Hans-Peter

Agent Davies Collison Cave

Pub. Number AU-B-2008340017

PCT Pub. Number WO2009/080759

Priority 07150326.2 21.12.07 EP

Filing date 19 December 2008

Wipo publication date 2 July 2009

Acceptance publication date 5 April 2012

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080759 Priority application(s): WO2009/080759

5 April 2012 Application Accepted

  Published as AU-B-2008340017

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008340019-Pharmaceutical composition

2008340011-PM-2 antibodies and methods for treating metastasis